- Home
- NCNA vs DSS Comparison
NCNA vs DSS Comparison
Compare NCNA & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- DSS
- Stock Information
- Founded
- NCNA 1997
- DSS 1984
- Country
- NCNA United Kingdom
- DSS United States
- Employees
- NCNA N/A
- DSS N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- NCNA Health Care
- DSS Consumer Discretionary
- Exchange
- NCNA Nasdaq
- DSS Nasdaq
- Market Cap
- NCNA 6.6M
- DSS 11.6M
- IPO Year
- NCNA 2017
- DSS N/A
- Fundamental
- Price
- NCNA $3.86
- DSS $1.28
- Analyst Decision
- NCNA
- DSS
- Analyst Count
- NCNA 0
- DSS 0
- Target Price
- NCNA N/A
- DSS N/A
- AVG Volume (30 Days)
- NCNA 346.4K
- DSS 788.2K
- Earning Date
- NCNA 08-20-2025
- DSS 11-12-2025
- Dividend Yield
- NCNA N/A
- DSS N/A
- EPS Growth
- NCNA N/A
- DSS N/A
- EPS
- NCNA N/A
- DSS N/A
- Revenue
- NCNA N/A
- DSS $21,252,000.00
- Revenue This Year
- NCNA N/A
- DSS N/A
- Revenue Next Year
- NCNA N/A
- DSS N/A
- P/E Ratio
- NCNA N/A
- DSS N/A
- Revenue Growth
- NCNA N/A
- DSS 10.24
- 52 Week Low
- NCNA $2.78
- DSS $0.72
- 52 Week High
- NCNA $1,650.00
- DSS $1.90
- Technical
- Relative Strength Index (RSI)
- NCNA 41.45
- DSS 56.02
- Support Level
- NCNA $2.82
- DSS $1.10
- Resistance Level
- NCNA $3.60
- DSS $1.44
- Average True Range (ATR)
- NCNA 0.24
- DSS 0.24
- MACD
- NCNA 0.43
- DSS -0.00
- Stochastic Oscillator
- NCNA 74.48
- DSS 41.80
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.